Gout is a common and complex form of arthritis characterized by severe pain, redness and tenderness in joints. Hyperuricemia, an elevated uric acid level in the blood, is a major cause of gout. The body makes uric acid when it breaks down purines, which are found in your body and the foods you eat. Nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and corticosteroids are used in the treatment of gout.
Major players operating in the global gouty arthritis market are focused on adopting partnership strategies to enhance their market share. For instance, in 2015, Prasco Laboratories partnered with Takeda Pharmaceutical Inc. for the distribution and supply of Colchicine Tablets, USP, a generic version of Colrycs, colchicine brand by Takeda Pharmaceutical Inc.
Get Free Request Sample Here @
https://www.coherentmarketinsights.com/insight/request-sample/1368
Approval and launch of new products is expected to propel growth of the global gouty arthritis market over the forecast period. For instance, in 2013, Novartis AG received approval from European Commission for Ilaris, a biologic product, in treatment of acute gouty arthritis for patients who suffer from frequent attacks of gouty arthritis.
Moreover, high prevalence of gouty arthritis is also expected to propel growth of the global gouty arthritis market over the forecast period. For instance, around 54.4 million patients annually suffered from some form of arthritis from 2013 – 2015, according to Centre for Disease Control and Prevention.
Major players operating in the global gouty arthritis market are focused on approval and launch of new products to expand their product portfolio. For instance, in August 2017, the U.S Food and Drug Administration approved Duzallo from Ironwood Pharmaceuticals for the treatment of hyperuricemia in patients with uncontrolled gout. Duzallo is a one a day combination oral treatment.
High prevalence of hypertension is expected to propel growth of the global gouty arthritis market over the forecast period. For instance, according to a study published in Journal of Rheumatology in 2014, around 75% hypertensive patients had gouty arthritis.
Asia Pacific is expected to witness significant growth in the global gouty arthritis market, owing to increasing geriatric population. For instance, according to The United Nations Economic and Social Commission for Asia and the Pacific, over a third of the population in Asia Pacific is expected to be 60 years or older by 2050.
North America is also expected to witness significant growth in the global gouty arthritis market, owing to High prevalence of gout. For instance, about 3.9% of U.S. adults older than 20 years reported about gout at least once in lifetime, according to clinical guidelines for gout published in Annals of Internal Medicine in 2017.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/1368
Lack of awareness about effective treatment of gout and high costs associated with treatment of the condition is expected to hinder growth of the global gouty arthritis market.
Major players operating in the global gouty arthritis market include, AstraZeneca plc, GlaxoSmithKline plc, JW Pharmaceutical Corporation, Merck& Co. Inc., Nippon Chemiphar Co. Ltd., Novartis AG, Regeneron Pharmaceuticals, Savient Pharmaceuticals, Teijin Pharma Ltd., and Takeda Pharmaceutical Company Ltd.
Major players operating in the global gouty arthritis market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2015, Astra Zeneca received U.S Food and Drug Administration approval for novel molecule lesinurad (Zurampic) tablets in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid (sUA) levels with an XOI alone.
Global Gouty Arthritis Market: Segmentation
On the basis of Drug Class
- NSAIDs
- Corticosteroids
- Colchicine
- Urate-lowering agents
On the basis of gouty types
- Acute gouty arthritis
Chronic gouty arthritis
Reasons to Buy this Gouty Arthritis Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Gouty Arthritis market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Gouty Arthritis market
➡Leading company profiles reveal details of key Gouty Arthritis market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Gouty Arthritis market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat 30% Off @
https://www.coherentmarketinsights.com/insight/buy-now/1368
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Gouty Arthritis Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Gouty Arthritis Industry Impact
Chapter 2 Global Gouty Arthritis Competition by Types, Applications, and Top Regions and Countries
2.1 Global Gouty Arthritis (Volume and Value) by Type
2.3 Global Gouty Arthritis (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Gouty Arthritis Sales, Consumption, Export, Import by Regions
Chapter 5 North America Gouty Arthritis Market Analysis
Chapter 6 East Asia Gouty Arthritis Market Analysis
Chapter 7 Europe Gouty Arthritis Market Analysis
Chapter 8 South Asia Gouty Arthritis Market Analysis
Chapter 9 Southeast Asia Gouty Arthritis Market Analysis
Chapter 10 Middle East Gouty Arthritis Market Analysis
Chapter 11 Africa Gouty Arthritis Market Analysis
Chapter 12 Oceania Gouty Arthritis Market Analysis
Chapter 13 South America Gouty Arthritis Market Analysis
Chapter 14 Company Profiles and Key Figures in Gouty Arthritis Business
Chapter 15 Global Gouty Arthritis Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodology….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837